SSTR2 and neoplasm: In this patient, the expression of SSTR2 was demonstrated on both primary tumour and metastases, and three months of treatment with lanreotide SR 30 mg administered twice a month induced a decrease in the size of the mediastinal nodes and complete disappearance of the lung nodes[210].